Results 171 to 180 of about 95,544 (345)

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay   +5 more
wiley   +1 more source

Psychodiagnostics and Differentiated Approach Criteria in Penitentiary Psychology [PDF]

open access: yesПенитенциарная наука
Introduction: the problem of identifying aggressiveness and criminal inclinations remains relevant in modern penitentiary science. Many psychologists have been using psychological diagnostic methods for many years, however, the number of works in the ...
LYUDMILA N. SOBCHIK
doaj  

Large‐cohort humanized NPI mice reconstituted with CD34 + hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapy [PDF]

open access: hybrid, 2022
Xiongfei Xu   +17 more
openalex   +1 more source

Model‐informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Population pharmacokinetic (popPK) and pharmacokinetic‐pharmacodynamic (PK/PD) models were developed to support clinical development of nemolizumab, a humanized monoclonal antibody targeting the IL‐31 receptor α, in adolescents and adults with moderate‐to‐severe atopic dermatitis (AD).
Floris Fauchet   +17 more
wiley   +1 more source

Pharmacokinetic‐pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Risankizumab is a high‐cost biologic treatment for chronic plaque psoriasis, an immune‐mediated inflammatory disease presenting with painful red scaly skin lesions. Inter‐individual heterogeneity in treatment response may be better addressed with personalised rather than fixed dosing. We sought to develop a pharmacokinetic/pharmacodynamic (
Charlotte M. Thomas   +16 more
wiley   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse   +3 more
wiley   +1 more source

HUMANIZACIÓN DEL CUIDADO DE ENFERMERÍA DURANTE EL PARTO HUMANIZATION IN THE INFIRMARY’S CARE TAKE DURING CHILDBIRTH

open access: yesRevista U.D.C.A Actualidad & Divulgación Científica, 2008
RESUMEN A lo largo de la trayectoria profesional en diferentes instituciones de salud y durante la experiencia de estar en contacto con las mujeres en trabajo de parto, se han reportado quejas de maltrato por parte del personal de salud.
Rosa Coral Ibarra
doaj  

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy